ArticleViruses2021

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.

Carla Prezioso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.